ArticleExperimental hematology & oncology2023

Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy.

Manling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.